Pick an NAD supplement that names its precursor — NR or NMN — and backs that dose with a batch certificate of analysis, not an anti-aging promise.
A bottle can promise better labs and sharper sleep while holding nothing but filler and the word “booster.” The label is the one part of the product you can audit before money changes hands, and it settles most of the question on its own.
Working out how to choose a high-quality NAD supplement comes down to paper, not promises: the precursor named on the Supplement Facts panel, a certificate of analysis tied to your specific lot, and a facility that follows FDA dietary-supplement cGMP rules. Start with those three and the marketing peels away.
Choosing A High-Quality NAD Supplement: What Decides The Outcome
Three things separate a defensible product from a hopeful one: a named precursor with a stated dose, purity testing tied to the batch you hold, and zero disease claims.
Nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN) are the two precursors with human trial data behind them. Oral NAD+ products sit on much thinner ground. Whichever form you land on, the panel has to say so plainly — “NAD booster” or “NAD+ complex” on the front tells you nothing about what is inside.
The label itself has to clear four bars:
- Named ingredient and dose. The Supplement Facts panel should list NR or NMN in milligrams per serving, plus serving size, lot number, expiration date, manufacturer, and every inactive ingredient. Proprietary blends that hide individual amounts leave you nothing to check.
- A lot-matched certificate of analysis. Ask the seller for one naming the lot on your bottle, reporting identity, potency, microbial testing, heavy metals, and residual solvents. A certificate from a different lot says nothing about the powder in your hand.
- Independent certification. USP or NSF verification outranks a manufacturer’s own “third-party tested” badge. Those programs check label contents and screen for contaminants — though neither proves the product improves your health.
- No disease claims. FDA does not approve dietary supplements for safety or effectiveness before sale.
When the shelves look alike, ingredient forms and testing records do the sorting — our tested quality NAD supplement picks lay out the options that publish what their labels claim.
| Form | Doses Used In Human Studies | What The Evidence Shows |
|---|---|---|
| Nicotinamide riboside (NR) | 500–2,000 mg/day for up to 12 weeks; 1,000 mg/day for up to five months | 24 published trials summarized by the National Institute on Aging; generally well tolerated, no clear efficacy for reviewed outcomes |
| Nicotinamide mononucleotide (NMN) | 250 mg/day for 6–12 weeks | Smaller, shorter trials; raised whole-blood NAD+ with no obvious adverse effects in 30 healthy adults |
| Oral NAD+ | No established clinical dose | A systematic review found no eligible clinical outcomes trials for anti-aging or wellness use |
| Niacin or nicotinamide | Not interchangeable with NR or NMN | Niacin can cause flushing and, at high doses, liver toxicity |
Do Human Trials Prove Any Benefit At All?
Not yet. Trials show NR and NMN reliably raise NAD-related metabolites in blood, while improvements in physical, metabolic, and vascular outcomes are inconsistent, often null, or limited to a single endpoint.
The National Institute on Aging’s workshop summary on NAD levels in older adults reviews 24 published NR trials, with doses up to 2,000 mg/day for 12 weeks and 1,000 mg/day for up to five months. NR was generally well tolerated, but the reviewed studies did not show clear efficacy for the outcomes measured.
NMN data is thinner. A randomized, placebo-controlled trial gave 250 mg/day for 12 weeks to 15 healthy participants and a placebo to 15 more; whole-blood NAD+ rose and no obvious adverse effects or abnormal lab findings appeared. A separate trial of 250 mg/day for 6 or 12 weeks in older men reported no serious adverse events. Thirty people is a pilot, not proof.
Two cautions matter before you buy. Short studies do not establish long-term safety, and reported events across reviews include gastrointestinal symptoms, nausea, fatigue, headache, muscle pain, skin rash, and lightheadedness. People who are pregnant or breastfeeding, under 18, or living with liver or kidney disease, cancer, or diabetes, and anyone on prescription medicines, should talk to a clinician first — the NIA summary notes no published NR studies in pregnant or lactating women. Do not confuse niacin or nicotinamide with NR or NMN.
NMN’s US status is unsettled. A 2023 review reports that FDA declared β-NMN prohibited as a health supplement on November 10, 2022, so confirm the current status before ordering.
What To Do When Two Bottles Look Identical
Run the checks in this order and the weaker bottle usually drops out by step two.
- Read the Supplement Facts panel: precursor named, milligrams stated, no blend hiding the dose.
- Match the certificate of analysis lot number to the bottle in your hand, then read what it tested for.
- Look for USP or NSF on the label; without either, that certificate carries the whole burden.
- Confirm the form is legal to sell in the US today — NMN especially — before paying.
Purity you can verify beats a promise you cannot.
Common Questions
Is NMN or NR the better choice?
Neither has won on health outcomes. NR has the larger published record, with 24 trials summarized by the National Institute on Aging. NMN’s human data comes from smaller, shorter studies. NMN also carries a US regulatory question after FDA’s 2022 position. Choose based on verifiable testing and current legal status, not marketing.
How much should I take each day?
No official recommended intake exists for NR or NMN. Published trials used roughly 500–2,000 mg/day of NR and 250 mg/day of NMN, but those are study doses, not recommendations. Anyone taking prescription medicine or managing a health condition should set the dose with a clinician rather than copying a trial.
Can a supplement slow aging?
No human evidence supports that claim. Trials show that NR and NMN raise NAD-related metabolites in blood, which is a lab measurement, not a proven change in lifespan, disease risk, or physical function. Products promising to reverse aging are making a claim FDA has not approved, and that belongs in your decision.
Sources
- National Institute on Aging. “NAD Levels in Older Adults — Workshop Program and Materials” Summarizes 24 published NR trials, doses, tolerability, and the absence of clear efficacy for reviewed outcomes.
- National Library of Medicine (PMC). “Nicotinamide Mononucleotide Trial and Regulatory Review” Supports the 250 mg/day, 12-week NMN trial details and the FDA β-NMN position of November 10, 2022.
- PubMed. “Systematic Review of NAD+ Supplementation” Underpins the finding that no eligible clinical outcomes trials exist for intravenous or intramuscular NAD+ in anti-aging or wellness use.